Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Amino Acids, Peptides, and Proteins > Peptides > Oligopeptides > Gonadotropin-Releasing Hormone > Nafarelin
... > Amino Acids, Peptides, and Proteins > Proteins > Nerve Tissue Proteins > Neuropeptides > Hypothalamic Hormones > Pituitary Hormone-Releasing Hormones > Gonadotropin-Releasing Hormone > Nafarelin
... > Amino Acids, Peptides, and Proteins > Peptides > Neuropeptides > Hypothalamic Hormones > Pituitary Hormone-Releasing Hormones > Gonadotropin-Releasing Hormone > Nafarelin
... > Chemical Actions and Uses > Pharmacologic Actions > Physiological Effects of Drugs > Hormones, Hormone Substitutes, and Hormone Antagonists > Hormones > Peptide Hormones > Hypothalamic Hormones > Pituitary Hormone-Releasing Hormones > Gonadotropin-Releasing Hormone > Nafarelin
... > Amino Acids, Peptides, and Proteins > Peptides > Peptide Hormones > Hypothalamic Hormones > Pituitary Hormone-Releasing Hormones > Gonadotropin-Releasing Hormone > Nafarelin

Preferred term

Nafarelin  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Nafarelin Acetate
  • Nafarelin Monoacetate
  • RS 94991 298
  • RS-94991-298
  • RS94991298
  • Synarel

Scope note

  • A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS.

History note

  • 93; was NAFARELIN (NM) 1981-92

In other languages

URI

http://www.yso.fi/onto/mesh/D017274

Download this concept:

RDF/XML TURTLE JSON-LD Created 5/22/92, last modified 11/24/15